Temat: "Antirheumatic Agents" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis.
Autorzy :: Li J; Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; Department of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Wang X; Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; Department of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Ruan G; Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhu Z; Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Ding C; Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.; Clinical Research Centre, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.; Pokaż więcej
Źródło :: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2021 Sep; Vol. 30 (9), pp. 923-930. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antirheumatic Agents/*administration & dosage
Fibroblast Growth Factors/*administration & dosage
Osteoarthritis, Knee/*drug therapy
Animals ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/pharmacology ; Cartilage, Articular/drug effects ; Cartilage, Articular/metabolism ; Drug Development ; Fibroblast Growth Factors/adverse effects ; Fibroblast Growth Factors/pharmacology ; Humans ; Osteoarthritis, Knee/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis.
Autorzy :: Osiri M; Division of Rheumatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathumwan, Bangkok, 10330, Thailand. .
Dilokthornsakul P; Center of Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
Chokboonpium S; Pfizer (Thailand) Limited, Bangkok, Thailand.
Suthipinijtham P; Pfizer (Thailand) Limited, Bangkok, Thailand.
Koolvisoot A; Division of Rheumatology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Pokaż więcej
Źródło :: Advances in therapy [Adv Ther] 2021 Sep; Vol. 38 (9), pp. 4885-4899. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Biosimilar Pharmaceuticals*/therapeutic use
Etanercept/therapeutic use ; Humans ; Thailand ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3.
Autorzy :: Aletaha D; Division of Rheumatology, Medical University of Vienna, Wien, Austria .
Westhovens R; Department of Development and Regeneration, KU Leuven University Hospitals Leuven, Leuven, Belgium.
Gaujoux-Viala C; Department of Rheumatologie, Centre Hospitalier Universitaire de Nîmes, Nimes, France.; UMR 1302 Institute Desbrest of Epidemiology and Public Health, INSERM, Université de Montpellier, Montpellier, France.
Adami G; Division of Rheumatology, University of Verona, Verona, Italy.
Matsumoto A; Arthritis and Rheumatism Associates PC, Wheaton, Maryland, USA.
Bird P; St George and Sutherland Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
Messina OD; Department of Rheumatology and Metabolic Bone Diseases, Investigaciones Reumatológicas y Osteológicas srl, Buenos Aires, Argentina.
Buch MH; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester, UK.
Bartok B; Gilead Sciences Inc, Foster City, California, USA.
Yin Z; Gilead Sciences Inc, Foster City, California, USA.
Guo Y; Gilead Sciences Inc, Foster City, California, USA.
Hendrikx T; Galapagos BV, Leiden, The Netherlands.
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Pokaż więcej
Źródło :: RMD open [RMD Open] 2021 Aug; Vol. 7 (2).
Typ publikacji :: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Antirheumatic Agents*/adverse effects
Arthritis, Rheumatoid*/drug therapy
Drug Therapy, Combination ; Humans ; Methotrexate/adverse effects ; Prognosis ; Pyridines ; Treatment Outcome ; Triazoles
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Impact of socio-demographic and clinical characteristics on functional disability and health-related quality of life in patients with rheumatoid arthritis: a cross-sectional study from Palestine.
Autorzy :: Al-Jabi SW; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. .
Seleit DI; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Badran A; Department of Rheumatology, Jenin Government Hospital, Palestinian Ministry of Health, Jenin, Palestine.
Koni A; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.; Division of Clinical Pharmacy, Hematology and Oncology Department, An-Najah National University Hospital, Nablus, 44839, Palestine.
Zyoud SH; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.; Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.; Clinical Research Centre, An-Najah National University Hospital, Nablus, 44839, Palestine.; Pokaż więcej
Źródło :: Health and quality of life outcomes [Health Qual Life Outcomes] 2021 Oct 13; Vol. 19 (1), pp. 241. Date of Electronic Publication: 2021 Oct 13.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Adult ; Aged ; Cross-Sectional Studies ; Female ; Humans ; Middle Aged ; Quality of Life ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 5 5.

Tytuł :: Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis.
Autorzy :: Zou A; Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Health Care Group, Huangshi, Hubei, China.; Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Huangshi, Hubei, China.
Chen Y; Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Health Care Group, Huangshi, Hubei, China.; Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Huangshi, Hubei, China.
Shi N; Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Health Care Group, Huangshi, Hubei, China.; Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Huangshi, Hubei, China.
Ye Y; Department of Radiology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Health Care Group, Huangshi, Hubei, China.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Oct 08; Vol. 100 (40), pp. e27368.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Antirheumatic Agents/*adverse effects
Arthritis, Psoriatic/*drug therapy
Biological Factors/*adverse effects
Herpes Zoster/*chemically induced
Adult ; Aged ; Antirheumatic Agents/administration & dosage ; Biological Factors/administration & dosage ; Female ; Humans ; Immunosuppression/adverse effects ; Immunosuppression/methods ; Male ; Middle Aged ; Observational Studies as Topic ; Randomized Controlled Trials as Topic ; Risk Assessment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: [Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding].
Autorzy :: Häfeli C; Universitätsklinik für Rheumatologie und Immunologie, Inselspital Bern, Freiburgstraße 18, 3010, Bern, Schweiz.
Förger F; Universitätsklinik für Rheumatologie und Immunologie, Inselspital Bern, Freiburgstraße 18, 3010, Bern, Schweiz. .; Pokaż więcej
Transliterated Title :: Aktuelles zur antirheumatischen Therapie bei Kinderwunsch, Schwangerschaft und Stillzeit.
Źródło :: Zeitschrift fur Rheumatologie [Z Rheumatol] 2021 Oct; Vol. 80 (8), pp. 716-725. Date of Electronic Publication: 2021 Sep 28.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antirheumatic Agents*/adverse effects
Pregnancy Complications*/drug therapy
Rheumatic Diseases*/drug therapy
Breast Feeding ; Female ; Humans ; Methotrexate/therapeutic use ; Pregnancy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry.
Autorzy :: Sebastiani M; Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Via del Pozzo, 41125, Modena, Italy. .
Venerito V; Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari, Italy.
Bugatti S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Bazzani C; Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy.
Biggioggero M; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Petricca L; Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Foti R; Rheumatology Unit, A.O.U. Policlinico San Marco, Catania, Italy.
Bortoluzzi A; Section of Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria di Ferrara, Ferrara, Italy.
Balduzzi S; Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Visalli E; Rheumatology Unit, A.O.U. Policlinico San Marco, Catania, Italy.
Frediani B; Rheumatology Unit, Department of Medical Sciences, Surgery e Neurosciences, University of Siena, Siena, Italy.
Manfredi A; Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Via del Pozzo, 41125, Modena, Italy.
Gremese E; Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Favalli E; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
Iannone F; Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari, Italy.
Ferraccioli G; Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Lapadula G; Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari, Italy.; Pokaż więcej
Corporate Authors :: Contributors
Źródło :: Clinical rheumatology [Clin Rheumatol] 2021 Oct; Vol. 40 (10), pp. 4039-4047. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :: Journal Article
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Biological Products*
Abatacept/therapeutic use ; Antibodies, Monoclonal, Humanized ; Humans ; Italy ; Registries ; Rituximab/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Efficacy of tight control strategy in the treatment of adult-onset Still disease.
Autorzy :: Malek Mahdavi A; Connective Tissue Diseases Research Center, Imam-Reza Hospital, Tabriz University of Medical Sciences, Flat 1, Golgasht St, P.O. Box 5166614756, Tabriz, Iran.
Khalili A; Connective Tissue Diseases Research Center, Imam-Reza Hospital, Tabriz University of Medical Sciences, Flat 1, Golgasht St, P.O. Box 5166614756, Tabriz, Iran.; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Alihosseini S; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Jaberinezhad M; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Esalatmanesh K; Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Hajialilo M; Connective Tissue Diseases Research Center, Imam-Reza Hospital, Tabriz University of Medical Sciences, Flat 1, Golgasht St, P.O. Box 5166614756, Tabriz, Iran.
Seyedmardani S; Rheumatology Section, Department of Internal Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Khabbazi A; Connective Tissue Diseases Research Center, Imam-Reza Hospital, Tabriz University of Medical Sciences, Flat 1, Golgasht St, P.O. Box 5166614756, Tabriz, Iran. .; Pokaż więcej
Źródło :: Clinical rheumatology [Clin Rheumatol] 2021 Oct; Vol. 40 (10), pp. 3941-3949. Date of Electronic Publication: 2021 May 10.
Typ publikacji :: Journal Article
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Still's Disease, Adult-Onset*/drug therapy
Adult ; Aged ; Glucocorticoids/therapeutic use ; Humans ; Prednisolone/therapeutic use ; Remission Induction
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Comparative efficacy and safety of secukinumab and ixekizumab in patients with active ankylosing spondylitis.
Autorzy :: Lee YH; Department of Rheumatology, Korea University College of Medicine, Seoul, Korea (Republic of). .; Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, 136-705, Seongbuk-gu, Seoul, Korea (Republic of). .
Song GG; Department of Rheumatology, Korea University College of Medicine, Seoul, Korea (Republic of).; Pokaż więcej
Transliterated Title :: Relative Wirksamkeit und Sicherheit von Secukinumab und Ixekizumab bei Patienten mit aktiver ankylosierender Spondylitis.
Źródło :: Zeitschrift fur Rheumatologie [Z Rheumatol] 2021 Oct; Vol. 80 (8), pp. 776-784.
Typ publikacji :: Journal Article; Meta-Analysis
MeSH Terms :: Antirheumatic Agents*/adverse effects
Spondylitis, Ankylosing*/drug therapy
Antibodies, Monoclonal, Humanized ; Bayes Theorem ; Humans ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Efficacy and safety of jakinibs in rheumatoid arthritis: a systematic review and meta-analysis.
Autorzy :: Yin Y; Department of Rheumatology, The First Affiliated Hospital of Soochow University, No. 188 Shizi St, Suzhou, 215006, Jiangsu, China.
Liu M; Department of Rheumatology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Zhou E; Department of Rheumatology, The First Affiliated Hospital of Soochow University, No. 188 Shizi St, Suzhou, 215006, Jiangsu, China.
Chang X; Department of Rheumatology, The First Affiliated Hospital of Soochow University, No. 188 Shizi St, Suzhou, 215006, Jiangsu, China.
He M; Department of Rheumatology, The First Affiliated Hospital of Soochow University, No. 188 Shizi St, Suzhou, 215006, Jiangsu, China.
Wang M; Department of Rheumatology, The First Affiliated Hospital of Soochow University, No. 188 Shizi St, Suzhou, 215006, Jiangsu, China.
Wu J; Department of Rheumatology, The First Affiliated Hospital of Soochow University, No. 188 Shizi St, Suzhou, 215006, Jiangsu, China. .; Pokaż więcej
Źródło :: Clinical rheumatology [Clin Rheumatol] 2021 Oct; Vol. 40 (10), pp. 3989-4005. Date of Electronic Publication: 2021 May 14.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Antirheumatic Agents*/adverse effects
Arthritis, Rheumatoid*/drug therapy
Double-Blind Method ; Humans ; Randomized Controlled Trials as Topic ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Combination of Methotrexate and Leflunomide Is Safe and Has Good Drug Retention Among Patients With Psoriatic Arthritis.
Autorzy :: Haroon M; Department of Rheumatology, Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Lahore, Pakistan. .
Batool S; Department of Rheumatology, Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Lahore, Pakistan.
Asif S; Department of Rheumatology, Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Lahore, Pakistan.
Hashmi F; Department of Rheumatology, Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Lahore, Pakistan.
Ullah S; Department of Rheumatology, Fatima Memorial Hospital & FMH College of Medicine and Dentistry, Lahore, Pakistan.; Pokaż więcej
Źródło :: The Journal of rheumatology [J Rheumatol] 2021 Oct; Vol. 48 (10), pp. 1624-1626. Date of Electronic Publication: 2021 May 15.
Typ publikacji :: Letter; Research Support, Non-U.S. Gov't
MeSH Terms :: Antirheumatic Agents*/adverse effects
Arthritis, Psoriatic*/drug therapy
Pharmaceutical Preparations*
Humans ; Leflunomide/therapeutic use ; Methotrexate/adverse effects
: Raport

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed.
Autorzy :: Daoussis D; Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504, Patras, Greece. .
Leonidou L; Department of Infectious Diseases, Patras University Hospital, University of Patras Medical School, Patras, Greece.
Kalogeropoulou C; Department of Radiology, Patras University Hospital, University of Patras Medical School, Patras, Greece.
Paliogianni F; Department of Microbiology, Patras University Hospital, University of Patras Medical School, Patras, Greece.
Tzouvelekis A; Department of Pneumonology, Patras University Hospital, University of Patras Medical School, Patras, Greece.; Pokaż więcej
Źródło :: Rheumatology international [Rheumatol Int] 2021 Oct; Vol. 41 (10), pp. 1839-1843. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :: Case Reports; Journal Article; Review
MeSH Terms :: Contraindications, Drug*
Antirheumatic Agents/*adverse effects
COVID-19/*immunology
Mixed Connective Tissue Disease/*drug therapy
Rituximab/*adverse effects
Aged ; Antirheumatic Agents/administration & dosage ; COVID-19/diagnosis ; Fatal Outcome ; Female ; Humans ; Infusions, Intravenous ; Male ; Rituximab/administration & dosage ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States.
Autorzy :: Raiker R; West Virginia University School of Medicine, Morgantown, WV, USA.
DeYoung C; Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
Pakhchanian H; George Washington University School of Medicine and Health Sciences, Washington, D.C., USA.
Ahmed S; Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, India.
Kavadichanda C; Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Gupta L; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow, Uttar Pradesh, India.
Kardeş S; Department of Medical Ecology and Hydroclimatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Electronic address: .; Pokaż więcej
Źródło :: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2021 Oct; Vol. 51 (5), pp. 1057-1066. Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/drug therapy
COVID-19*
Adult ; Cohort Studies ; Humans ; Male ; SARS-CoV-2 ; Tumor Necrosis Factor Inhibitors ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model.
Autorzy :: Dos Santos JBR; Health Assessment, Technology, and Economy Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Espírito Santo, Brazil.; Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
da Silva MRR; Health Assessment, Technology, and Economy Group, Center for Exact, Natural and Health Sciences, Federal University of Espírito Santo, Alegre, Espírito Santo, Brazil.; Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Almeida AM; Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Minas Gerais, Brasil.
Acurcio FA; Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Department of Social and Preventive Medicine, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Alvares-Teodoro J; Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.; Pokaż więcej
Źródło :: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Oct; Vol. 21 (5), pp. 1011-1016. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: Models, Economic*
Antirheumatic Agents/*administration & dosage
Arthritis, Rheumatoid/*drug therapy
Tumor Necrosis Factor Inhibitors/*administration & dosage
Adalimumab/administration & dosage ; Adalimumab/economics ; Adult ; Aged ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/economics ; Antirheumatic Agents/economics ; Arthritis, Rheumatoid/economics ; Brazil ; Cohort Studies ; Cost-Benefit Analysis ; Etanercept/administration & dosage ; Etanercept/economics ; Female ; Follow-Up Studies ; Humans ; Male ; Markov Chains ; Middle Aged ; Prospective Studies ; Tumor Necrosis Factor Inhibitors/economics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
Autorzy :: Pombo-Suarez M; Department of Rheumatology, Hospital Universitario de Santiago de Compostela, Rúa da Choupana, s/n, 15706 Santiago de Compostela, A Coruña, Spain. .
Sanchez-Piedra C; Clinical Research Unit, Spanish Society of Rheumatology (SER), Madrid, Spain.
Garcia-Magallón B; Department of Rheumatology, Hospital San Jorge, Huesca, Spain.
Pérez-Gómez A; Department of Rheumatology, Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Manrique-Arija S; Department of Rheumatology, Hospital Carlos Haya, Málaga, Spain.
Martín-Doménech R; Department of Rheumatology, Hospital de Elda, Alicante, Spain.
Colazo M; Department of Rheumatology, Hospital Universitario de Burgos, Burgos, Spain.
Campos C; Department of Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain.
Campos J; Department of Rheumatology, Hospital Puerta de Hierro, Madrid, Spain.
Del Pino-Montes J; Department of Rheumatology, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
Arteaga MJ; Medical Affairs Department, MSD Spain, Madrid, Spain.
Cea-Calvo L; Medical Affairs Department, MSD Spain, Madrid, Spain.
Díaz-González F; Department of Rheumatology, Hospital Universitario de Canarias, Sta Cruz de Tenerife, Spain.
Gómez-Reino JJ; Department of Rheumatology, Hospital Universitario de Santiago de Compostela, Rúa da Choupana, s/n, 15706 Santiago de Compostela, A Coruña, Spain.; Pokaż więcej
Źródło :: Clinical rheumatology [Clin Rheumatol] 2021 Oct; Vol. 40 (10), pp. 3979-3988. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :: Journal Article
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Arthritis, Psoriatic*/drug therapy
Arthritis, Rheumatoid*/drug therapy
Spondylarthritis*/drug therapy
Adult ; Antibodies, Monoclonal ; Humans ; Registries ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Methotrexate-Induced Pneumonitis in a Patient With Psoriatic Arthritis and Erythroderma.
Autorzy :: Liu ZH; From the Department of Dermatology, Affiliated Hangzhou Third Hospital, Anhui Medical University, Hangzhou, China.
Shen H; Pokaż więcej
Źródło :: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2021 Oct 01; Vol. 27 (7), pp. e260-e261.
Typ publikacji :: Journal Article
MeSH Terms :: Antirheumatic Agents*/adverse effects
Arthritis, Psoriatic*/complications
Arthritis, Psoriatic*/drug therapy
Dermatitis, Exfoliative*/chemically induced
Dermatitis, Exfoliative*/diagnosis
Dermatitis, Exfoliative*/drug therapy
Pneumonia*/chemically induced
Pneumonia*/diagnosis
Humans ; Methotrexate/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Nocebo effects of Janus kinase inhibitors in the treatment of active ankylosing spondylitis.
Autorzy :: Lee YH
Song GG; Pokaż więcej
Źródło :: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2021 Oct; Vol. 59 (10), pp. 668-670.
Typ publikacji :: Journal Article
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Janus Kinase Inhibitors*/adverse effects
Spondylitis, Ankylosing*/drug therapy
Humans ; Nocebo Effect
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Does being exposed to an educational tool influence patient preferences? The influence of an educational tool on patient preferences assessed by a discrete choice experiment.
Autorzy :: Bywall KS; Department of Public Health and Caring Sciences, Centre for Research Ethics & Bioethics, Uppsala University, Uppsala, Sweden. Electronic address: .
Veldwijk J; Department of Public Health and Caring Sciences, Centre for Research Ethics & Bioethics, Uppsala University, Uppsala, Sweden; Erasmus School of Health Policy & Management, and Erasmus Choice Modelling Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: .
Hansson MG; Department of Public Health and Caring Sciences, Centre for Research Ethics & Bioethics, Uppsala University, Uppsala, Sweden. Electronic address: .
Baecklund E; Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden. Electronic address: .
Raza K; Institute of Inflammation and Ageing, University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, UK; Sandwell and West Birmingham NHS Trust, Birmingham, UK. Electronic address: .
Falahee M; Institute of Inflammation and Ageing, University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, UK. Electronic address: .
Kihlbom U; Department of Public Health and Caring Sciences, Centre for Research Ethics & Bioethics, Uppsala University, Uppsala, Sweden. Electronic address: .; Pokaż więcej
Źródło :: Patient education and counseling [Patient Educ Couns] 2021 Oct; Vol. 104 (10), pp. 2577-2585. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Choice Behavior ; Educational Status ; Humans ; Patient Preference
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Utilization of targeted disease-modifying anti-rheumatic drugs (DMARDs) for managing rheumatoid arthritis in the last decade: A two-country comparison.
Autorzy :: Park SH
Jeon HL
Kim SC
Hillen J
Gadzhanova S
Shin JY
Pratt N; Pokaż więcej
Źródło :: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2021 Oct; Vol. 59 (10), pp. 639-644.
Typ publikacji :: Journal Article
MeSH Terms :: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Biological Products*/therapeutic use
Adalimumab/therapeutic use ; Cost-Benefit Analysis ; Etanercept/therapeutic use ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system.
Autorzy :: Kip MMA; Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands.; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).
de Roock S; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Pediatric Rheumatology, Division of Paediatrics, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands.
Currie G; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Paediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
Marshall DA; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Grazziotin LR; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Twilt M; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.; Division of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Yeung RSM; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Division of Rheumatology, the Hospital for Sick Children, Department of Paediatrics, Immunology and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Benseler SM; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.; Division of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Schreijer MA; Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands.
Vastert SJ; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Pediatric Rheumatology, Division of Paediatrics, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands.; European Reference Network RITA (Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases Network).
Wulffraat N; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Pediatric Rheumatology, Division of Paediatrics, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands.; European Reference Network RITA (Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases Network).
van Royen-Kerkhof A; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Pediatric Rheumatology, Division of Paediatrics, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands.; European Reference Network RITA (Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases Network).
Swart JF; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; Department of Pediatric Rheumatology, Division of Paediatrics, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands.; European Reference Network RITA (Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases Network).
IJzerman MJ; Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands.; UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases).; University of Melbourne, Melbourne School of Population and Global Health, Parkville, Melbourne, Australia.; Pokaż więcej
Źródło :: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Oct; Vol. 21 (5), pp. 975-984. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji :: Journal Article
MeSH Terms :: Antirheumatic Agents/*administration & dosage
Arthritis, Juvenile/*drug therapy
Biological Products/*administration & dosage
Adolescent ; Antirheumatic Agents/economics ; Arthritis, Juvenile/economics ; Biological Products/economics ; Child ; Child, Preschool ; Delivery of Health Care/economics ; Drug Costs ; Female ; Humans ; Infant ; Male ; Netherlands ; Retrospective Studies ; Time Factors
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Antirheumatic Agents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język